58610-61-0 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 5-cyano-4-methyl-6-oxo-1,6-dihydropyridine-2-carboxylate is used as a building block for the synthesis of various pharmaceuticals due to its diverse pharmacological properties. Its calcium channel blocking and antioxidant activities contribute to the development of drugs for treating cardiovascular diseases and other conditions.
Used in Agrochemical Industry:
In the agrochemical industry, ethyl 5-cyano-4-methyl-6-oxo-1,6-dihydropyridine-2-carboxylate is utilized as a key intermediate in the synthesis of agrochemicals, such as pesticides and herbicides, to enhance crop protection and yield.
Used in Medicinal Chemistry Research:
Ethyl 5-cyano-4-methyl-6-oxo-1,6-dihydropyridine-2-carboxylate is used as a potential anti-inflammatory and antitumor agent in medicinal chemistry research. Its biological activity and diverse pharmacological properties make it a promising candidate for the development of new therapeutic agents to treat inflammation and cancer.
Overall, ethyl 5-cyano-4-methyl-6-oxo-1,6-dihydropyridine-2-carboxylate is a versatile chemical with various applications in the fields of medicine and agriculture, playing a crucial role in the synthesis of pharmaceuticals, agrochemicals, and as a subject of research for new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 58610-61-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,6,1 and 0 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 58610-61:
(7*5)+(6*8)+(5*6)+(4*1)+(3*0)+(2*6)+(1*1)=130
130 % 10 = 0
So 58610-61-0 is a valid CAS Registry Number.
58610-61-0Relevant academic research and scientific papers
PYRAZOLOPYRIDINE PYRAZOLOPYRIMIDINE AND RELATED COMPOUNDS
-
Paragraph 0258; 0260, (2015/11/25)
In one aspect this invention relates generally to compounds of Formula: and sub-formulas thereof, or a tautomer of each thereof, a pharmaceutically acceptable salt of each thereof, or a pharmaceutically acceptable solvate of each of the foregoing, where X1, L1, L3, and R3 are described herein.
METHOD OF TREATMENT
-
, (2014/09/29)
The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
-
, (2013/12/03)
This invention relates to novel substituted benzamide according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.
Novel syntheses of camptothecin alkaloids. Part I. Intramolecular [4 + 2] cycloadditions of N-arylimidates and 4H-3,1-benzoxazin-4-ones as 2-aza-1,3-dienes
Fortunak, Joseph M.D.,Mastrocola, Antonietta R.,Mellinger, Mark,Sisti, Nicolas J.,Wood, Jeffery L.,Zhuang, Zhi-Ping
, p. 5679 - 5682 (2007/10/03)
The first reported intramolecular [4 + 2] cycloadditions of both N-arylimidates and 4H-3,1-benzoxazin-4-ones acting as 2-aza-1,3-dienes are described. Reaction with unactivated alkynes leads to pyrrolo[3,4-b]quinolines which constitute the ABC ring system of camptothecins.